Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance
2021 · Nature Communications · 269 citations
https://doi.org/10.1038/s41467-021-23793-7
A
Aiko Yamaguchi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
114
Papers
2.0K
Citations
23
h-index
42
i10-index
Aiko Yamaguchi is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Radiopharmaceutical Chemistry and Applications & HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 23, co-authored 97 publications.
ORCID: 0000-0002-7631-3164Papers by this author
worksMyocardial fatty acid uptake through CD36 is indispensable for sufficient bioenergetic metabolism to prevent progression of pressure overload-induced heart failure
2018 · Scientific Reports · 48 citations
https://doi.org/10.1038/s41598-018-30616-1
Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors
2022 · Cell Reports · 46 citations
https://doi.org/10.1016/j.celrep.2022.110839
Circulating FABP4 is eliminated by the kidney via glomerular filtration followed by megalin-mediated reabsorption
2018 · Scientific Reports · 34 citations
https://doi.org/10.1038/s41598-018-34902-w
Reduced fatty acid uptake aggravates cardiac contractile dysfunction in streptozotocin-induced diabetic cardiomyopathy
2020 · Scientific Reports · 17 citations
https://doi.org/10.1038/s41598-020-77895-1
Differentiation of malignant tumours from granulomas by using dynamic [18F]-fluoro-L-α-methyltyrosine positron emission tomography
2015 · EJNMMI Research · 6 citations
https://doi.org/10.1186/s13550-015-0109-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat